RBI
WST icon

Raiffeisen Bank International’s West Pharmaceutical WST Stock Holding History

Raiffeisen Bank International’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.7K Hold
68
– – ﹤0.01% 667
2025
Q4 		$18.8K Hold
68
– – ﹤0.01% 627
2025
Q3 		$17.7K Buy
+68
New +$16.5K ﹤0.01% 635
2025
Q1 		– Sell
-674
Closed -$222K – 644
2024
Q4 		$222K Buy
+674
New +$212K ﹤0.01% 429

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raiffeisen Bank International's WST Position: Q1 2026 in Review

Raiffeisen Bank International held its West Pharmaceutical (WST) position steady in Q1 2026 at 68 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Raiffeisen Bank International first reported a position in WST in Q4 2024 and has held it in 4 quarters since. The position peaked at $222K in Q4 2024. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Raiffeisen Bank International held 68 shares of West Pharmaceutical worth $16.7K as of Q1 2026.
  • Raiffeisen Bank International left its West Pharmaceutical share count unchanged in Q1 2026.
  • West Pharmaceutical made up ﹤0.01% of Raiffeisen Bank International's portfolio in Q1 2026, its #667 holding.
  • Raiffeisen Bank International first reported a position in West Pharmaceutical in Q4 2024 and has held it in 4 quarters since.
  • Raiffeisen Bank International's West Pharmaceutical position peaked at $222K in Q4 2024.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.